Four hub genes, namely TOP2A (p=0.036), MELK (p=0.021), PBK (p=0.043), and RRM2 (p=0.012), were upregulated during breast cancer progression from normal tissue to DCIS and downregulated during disease progression from DCIS to IDC. Here, RRM2 is linked to ductal breast carcinoma in situ.